First patient included in the CRUZ-SENIOR STUDY.
Another important milestone has been achieved, allowing the Institute for Myocardial Infarction Research to generate new data to understand the efficacy and safety of cangrelor in high-risk patients.
Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.
| Renewed interim analysis of the COVID-19 registry provides important information on the situation in hospitals.
Presentation of the second evaluation of the COVID-19 registry for Rhineland-Palatinate by Dr. Anselm K. Gitt, board of directors of Foundation Institute for Myocardial Infarction Research in and study director of the COVID-19 registry...
The ethics committee approved the observational monitoring design for the CAN-SHOCK registry with no further conditions.
"The future depends on what we do today." Mahatma Gandhi
Minister Sabine Bätzing-Lichtenthäler of the Ministry of Social Affairs, Labour, Health and Demography (MSAGD) of the federal state of Rhineland-Palatinate and the Institute for Myocardial Infarction Research (IHF) presented first results of the...
The Institute for Myocardial Infarction Research (IHF) has started preparations for one of the largest coronary stent register.
Recruitment for the PASSPORT-HF study conducted by IHF has started with the inclusion of the first patient!
With Dr. Andreas Schemenewitz, the IHF GmbH gets an additional energetic contribution to expansion and strengthening of the market position as well as for the combination of scientific and medical competence and innovative, researching industrial...